This study aims to explore this gap by utilizing data from the large community-based database, TriNetX, to investigate the association between GLP-1 RA use and the risk of psychiatric diseases, including major depression, anxiety and suicidal behaviour in patients with obesity
Products are not intended for human or animal consumption, or to diagnose, treat, cure, or prevent any disease
However, recent studies, particularly the head-to-head trials, suggest that tirzepatide (Zepbound) generally leads to greater average weight loss than semaglutide (Wegovy)
The goal is to help you set realistic expectations, understand what youre experiencing, and have clearer conversations about next steps in your care